Decreased Whole Body Endogenous Nitric Oxide Production in Patients with Primary Pulmonary Hypertension

Authors:
  • THTim W. Higenbottam
    Tim W. Higenbottam
  • DKDavid G. Kiely
    David G. Kiely
  • JWJu-Ming Wong
    Ju-Ming Wong
  • SWSimon Wharton
    Simon Wharton
  • RVRichard Varcoe
    Richard Varcoe
  • TSTom Siddons
    Tom Siddons
  • ASAlan C. Spivey
    Alan C. Spivey
  • KHKeith Hall
    Keith Hall
  • AGAndy P. Gize
    Andy P. Gize

Abstract
Impaired pulmonary release of nitric oxide (NO) is one of the characteristic phenotypic changes of vascular cells in pulmonary hypertension. The aim of this study was to determine nitric oxide synthase (NOS)-dependent whole body NO production in patients with primary pulmonary hypertension. NOS-dependent whole body NO production was assessed by giving an intravenous infusion of L-[15N]2-arginine (50 µmol/min for 30 min) and measuring isotopic urinary enrichment of 15N-nitrite and 15N-nitrate. Four female patients with no signs of infection were recruited and compared with 6 age-matched control subjects. Mean 12-hour excretion of 15N-nitrite and 15N-nitrate in the total urine over 36 h was smaller in patients than in control subjects (57.2 ± 27.6 vs. 229.1 ± 65.2 nmol/mmol creatinine, p< 0.01, Mann-Whitney U test, respectively). Neither mean 12-hour excretion of 14N-nitrite and 14N-nitrate (51.6 ± 10.0 vs. 72.4 ± 10.0 µmol/mmol creatinine, p = 0.3) nor glomerular filtration rates (84.5 ± 15.8 vs. 129.7 ± 16.0 ml/min, p = 0.1) were different between patients and control subjects. Our results suggest that either basal NOS-dependent whole body NO production is impaired or excess NO metabolism occurs in patients with primary pulmonary hypertension.

This publication has 16 references indexed in Scilit: